This chemical is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds that target specific biological pathways, often in the context of treating diseases related to the central nervous system or metabolic disorders. Its structure, featuring a trifluoromethyl group, enhances the stability and bioavailability of the resulting drug molecules. Additionally, it is used in peptide synthesis, where it acts as a protecting group for amino acids, ensuring selective reactions during the formation of complex peptide chains. Its application is crucial in medicinal chemistry for designing and optimizing drug candidates with improved efficacy and reduced side effects.